'Regenerative medicine in Europe' project closing conference, Bilbao, Spain
The conference will announce the principal findings of the Remedie project. The project has explored developments in the political, socio-economic, legal and bioethical domains in the field of regenerative medicine (RM), both in Europe and at the global level.
Regenerative medicine involves the application of novel biomaterials - specifically cells (including stem cells), genes (via gene therapy) and biodegradable scaffolding materials, to achieve a regenerative effect, i.e. technologies aimed at stimulating or augmenting the human body's inherent capacity for self-repair.
Findings will be presented through an integrated series of presentations that cover these domains and their implications for clinical translation, and for regulatory policy. The key issues covered include:
- geographical and technological stratification of the European RM sector;
- the distinctive innovation and governance models being developed in India, China and Japan;
- the specific challenges associated with developing large-scale trials and pressures towards harmonisation across Europe;
- the emergence of indirect forms of commercialisation and the regulatory challenges that need to be addressed.
- the emergence of distinctive and competing bioethical networks that frame RM in very different ways.For further information, please visit: www.york.ac.uk/satsu/remedie/events/